It suggested that the level of resistance of isolates would be related to selecting pressure of fluoroquinolones and induced gene mutations of DNase and topoisomerase IV could not activate AcrAB efflux pump system.
英
美
- 提示臨床分離的雞大腸桿菌O 78的耐藥水平與喹諾酮類(lèi)藥物的選擇性壓力有關(guān),它誘導了DNA旋轉酶和拓撲異構酶IV的基因突變,可能不能激活A crAB外輸泵。